Peptide Batch Traceability: From Synthesis Lot to Labeled Vial

What a batch or lot is, and why one number must follow the material#

In manufacturing language, a batch is a defined quantity of material made under one production order in a single manufacturing cycle and intended to have uniform character and quality. US current good manufacturing practice (CGMP) regulations define it that way, and define a lot as a batch, or a specific identified portion of a batch, that has uniform character and quality within specified limits.^[1] The two words are often used interchangeably; the important point is that everything sharing one number is meant to be the same material.

The lot number (also called a batch or control number) is the identifier attached to that material. The same regulation describes it as any distinctive combination of letters, numbers or symbols from which the complete history of manufacture, processing, packing, holding and distribution can be determined.^[1] That is the core idea of batch traceability: given a number on a container, you should be able to walk backward through every recorded step that produced what is inside it.

Traceability matters because analytical results describe samples, not brands. A purity figure or a mass spectrum is meaningful only for the material that was actually tested. The lot number is what lets a reader connect a test result to a specific container, and it is only as useful as the records behind it.

The chain: synthesis lot, purification, lyophilization, fill, label#

For a synthetic peptide, the path from raw materials to a labeled vial usually passes through several distinct stages. Each stage can create a new record, and sometimes a new identifier, so the question at every step is whether the link to the previous stage is written down.

Two features of this chain deserve attention. First, the identifier can legitimately change: a single purified bulk lot may be filled into several fill lots, or a fill lot may be one identified portion of a larger batch, which the CGMP definition of a lot allows for.^[1] What matters is that each new number points back to its parent. Second, combining material is a deliberate act that needs its own record. ICH Q7, the international good manufacturing practice guide for active pharmaceutical ingredients (APIs), states that the batch record of a blending process should allow traceability back to the individual batches that make up the blend.^[3] For background on the drying step, see understanding lyophilization.

Batch records and what they document#

A batch record is the documented history of one batch. Under 21 CFR 211.188, batch production and control records for finished drug products must include, among other things:^[2]

• Dates of each significant step
• The major equipment and production lines used
• Specific identification of each batch of component or in-process material used
• Weights and measures of components
• In-process and laboratory control results
• Actual yield and percentage of theoretical yield at appropriate phases
• Complete labeling control records, including copies of all labeling used
• Any sampling performed
• Identification of the people who performed, supervised or checked each significant step

ICH Q7 sets out comparable expectations for APIs: records should contain complete information on the production and control of each batch, should carry a unique batch or identification number, and should be dated and signed when issued.^[3] Q7 also calls for records that trace the use of materials and for a system by which the distribution of each batch can be readily determined.^[3]

These regulations apply to products within their legal scope; research-grade materials are not necessarily made under them. They are still the clearest published description of what a complete batch history looks like, which makes them a useful benchmark when reading any supplier's documentation.

Linking a COA to a vial: matching lot numbers and dates#

A certificate of analysis (COA) reports test results for a specific batch. ICH Q7 expects authentic certificates to be issued for each batch, dated and signed by authorized quality personnel, and, when material has been repacked or reprocessed, to name the repacker and refer back to the original manufacturer.^[3] Our guide on how to read a certificate of analysis covers the document itself; here the focus is on the link to the container.

A practical check has a few parts:

1. Match the lot number exactly. The number on the vial label and the number on the COA should be identical, character for character. A near match is not a match.
2. Check the sequence of dates. The manufacture date should precede the test date, and the COA should be issued after testing is complete. A report dated before the material existed is a red flag.
3. Confirm what was tested. The COA should state whether the sample was taken from the bulk lot or from filled units. If the vial carries a fill lot number, there should be a documented link from that fill lot to the tested bulk lot.
4. Identify the testing laboratory. ISO/IEC 17025 sets requirements for the competence, impartiality and consistent operation of testing and calibration laboratories, and accreditation bodies use it to assess them.^[5] Knowing which laboratory performed a test lets you ask which methods and which accreditation scope applied.

What breaks traceability#

Traceability rarely fails in one dramatic step. More often a link quietly goes missing. Common failure points include:

• Relabeling without a record. If material is repackaged or given a new label, the new lot number must map to the original one. ICH Q7 expects repackaging and relabeling to be done under appropriate GMP controls and expects distributors to keep the original manufacturer's identity and batch number.^[3]
• Pooled or blended lots. Combining material from several lots without recording which lots went in, and in what amounts, makes the result untraceable. ICH Q7 also states that out-of-specification batches should not be blended to meet specifications.^[3]
• Unlabeled holding. Filled containers set aside before labeling are a classic source of mix-ups; CGMP rules require them to be identified, including by lot number, while they wait.^[4]
• Missing or altered records. A lot number with no retrievable history is only a label. Records also need to be trustworthy: FDA's data integrity guidance describes reliable data as attributable, legible, contemporaneously recorded, original or a true copy, and accurate.^[6] See laboratory documentation standards for more on those principles.
• Reused or generic numbers. If the same lot number appears on material made at different times, or a COA lists no lot number at all, the link between document and container cannot be established.

Evidence and limitations: what a lot number cannot prove on its own#

A lot number is an index, not evidence. It tells you where the evidence should be filed. On its own it cannot confirm identity, purity or content; those come from analytical testing, such as HPLC and mass spectrometry. Nor can it confirm that a particular vial is representative of the lot, because a COA usually reflects a sample, and the sampling plan determines how far the result can be generalized.

The strongest traceability is a chain in which each record points to the next, each is dated and attributable to a person, and each can be retrieved on request. When any link is missing, the honest conclusion is that the connection between the result and the container is unverified, not that it is wrong. Renuvia Labs publishes each batch's COA in the COA library when testing is complete.